Liftstream is an executive search recruitment company in the life sciences sector
Previously names Cell Therapeutics now CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) have appointment Bruce Seeley as Executive Vice President and Chief Commercial Officer, reporting to James Bianco, M.D., CTI BioPharma’s President and Chief Executive Officer. Seeley joins CTI BioPharma at the beginning of August 2015 and will serve on the executive leadership team, assuming responsibility for CTI BioPharma’s commercial organization worldwide – including sales, marketing, commercial operations, medical affairs and supply chain.
Oncology drug development is one of the largest areas within the pharmaceutical industry, addressing a disease area that causes more deaths than all other diseases apart from cardiovascular. The current global oncology market is estimated to be in the region of $55bn and forecast to grow to over $70bn by 2016. The oncology market is often seen as the most diverse with a wide range of indications and there are some 900 estimated clinical programmes currently underway. It is estimated that there are more than 200 different forms of cancer and therefore the oncology market presents a unique set of challenges to the industry.